Rheumatology/Endocrinology/Orthopedics:

Lupus exacerbation: https://onlinelibrary.wiley.com/doi/10.1111/dth.15017

Lupus exacerbation following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34291477/

Systemic lupus following vaccination: https://pubmed.ncbi.nlm.nih.gov/34418261/

Relapse of class V lupus. Nephritis after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34352310/

Subacute cutaneous lupus erythematosus flare triggered by Moderna: https://pubmed.ncbi.nlm.nih.gov/34455671/

Emergence of new onset SLE following vaccination: https://pubmed.ncbi.nlm.nih.gov/34450645/

Hyperglycemic crisis: https://onlinelibrary.wiley.com/doi/abs/10.1111/dme.14631

Perturbation of blood glucose following vaccination, a review of 20 adults: https://pubmed.ncbi.nlm.nih.gov/34375490/

Subacute Thyroiditis: https://www.tandfonline.com/doi/abs/10.1080/21645515.2021.1947102?fbclid=IwAR02FYW94iQGbu6e2uTpD42XoIwp6QHzwhDBWotULtT4ZCGR5sVKkyexbRg

Two cases of subacute thyroiditis after Moderna and AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34504856/

Two cases of Graves disease following vaccination: https://pubmed.ncbi.nlm.nih.gov/33858208/

Two more cases of Graves disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34342859/

5 cases of adrenal crisis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34358373/

Myositis in a 56yoF following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/33647971/

mRNA induced rhabdomyolysis and fasciitis: https://pubmed.ncbi.nlm.nih.gov/34435250/

Rhabdomyolysis after Moderna: https://pubmed.ncbi.nlm.nih.gov/34150372/

21yoM with Pfizer induced rhabdomyolysis: https://pubmed.ncbi.nlm.nih.gov/34186348/

Quadrilateral space region inflammation and other incidental findings on shoulder MRI following Pfizer COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34306275/

Rash, arthritis, swelling, muscle weakness following AstraZeneca: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27175

Polyarthralgia and Myalgia syndrome after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34463066/

40yoF with Henoch-Schonlein Purpura following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241653/

New onset mainly guttate psoriasis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34309932/

2 cases of exacerbation of plaque psoriasis after Pfizer and CoronaVac: https://pubmed.ncbi.nlm.nih.gov/34427024/

14 cases of psoriasis activation following vaccination (Moderna, Pfizer, and AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34363647/

Pustuluar psoriasis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34398977/

Psorasis exacerbation after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34487570/

Arthritis in the L elbow following vaccination: https://pubmed.ncbi.nlm.nih.gov/34363344/

Vasculitis and bursitis on 18F FDG-PET/CT following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34495381/

Remitting seronegative symmetrical synovitis with pitting edema following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34348912/

Scleroderma renal crisis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34339745/

Adult onset Still’s disease following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34316728/

Adult onset Still’s disease following mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34316726/

Hyper-inflammation after COVID-19 mRNA vaccination: at the cross roads of multi-inflammatory disease and adult onset still’s disease:

https://pubmed.ncbi.nlm.nih.gov/34487678/

Immune mediated disease flares: https://pubmed.ncbi.nlm.nih.gov/33946748/

Local and systemic reactogenicity of Pfizer in patients with systemic lupus and rheumatoid arthritis: https://pubmed.ncbi.nlm.nih.gov/34476603/

Incidence of disease flare after Pfizer vaccination in patients with rheumatoid arthritis in remission: https://pubmed.ncbi.nlm.nih.gov/34472714/

11% of patients with rheumatic and MSK diseases report disease flare following 2 dose mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34346185/